Microbiome Bristol Myers Squibb Moves Into In Vivo CAR T with $1.5 Billion Orbital BuyBy adminOctober 11, 20250 Credit: Pixelbizz/Getty Images Big pharma Bristol Myers Squibb (BMS) has agreed to acquire RNA biotech Orbital Therapeutics for $1.5 Billion.…
